Hemophagocytic lymphohistiocytosis: Unraveling the role of SARS-CoV-2 infection
Status PubMed-not-MEDLINE Language English Country Netherlands Media electronic-ecollection
Document type Editorial
PubMed
40978694
PubMed Central
PMC12447879
DOI
10.1016/j.gendis.2025.101764
PII: S2352-3042(25)00253-3
Knihovny.cz E-resources
Department of Toxicology Poznan University of Medical Sciences Poznań 61 701 Poland
Physiology Graduate Faculty North Carolina State University Raleigh NC 27607 USA
Prestage Department of Poultry Science North Carolina State University Raleigh NC 27607 USA
See more in PubMed
Chinnici A., Beneforti L., Pegoraro F., et al. Approaching hemophagocytic lymphohistiocytosis. Front Immunol. 2023;14 PubMed PMC
Khan M., Agudile E.P., Adhikari J., et al. Hemophagocytic lymphohistiocytosis (HLH) in a post-COVID-19 infection: a case report. Blood. 2023;142(Supplement 1):5367.
Jeyakanthan T., Ladel L., Khandpur B., Tan W.Y., Nasir S.A. Coronavirus does it again: post-COVID-19 hemophagocytic lymphohistiocytosis (HLH) Cureus. 2023;15(2) PubMed PMC
Fadlallah M.M., Salman S.M., Fadlallah M.M., Rahal H. Hemophagocytic syndrome and COVID-19: a comprehensive review. Cureus. 2023;15(3) PubMed PMC
Hoffmann M., Kleine-Weber H., Schroeder S., et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271–280.e8. PubMed PMC